The FDA has approved mirikizumab as a treatment for induction and maintenance therapy in certain patients.
retrieved 30 October 2023 from https://medicalxpress.com/news/2023-10-fda-mirikizumab-induction-maintenance-therapy.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.
FDA Mirikizumab Induction Therapy Maintenance Therapy Treatment
Danmark Seneste Nyt, Danmark Overskrifter
Similar News:Du kan også læse nyheder, der ligner denne, som vi har indsamlet fra andre nyhedskilder.
Jersey Trees for Life Receives Grant for Tool MaintenanceJersey Trees for Life (JTFL) has been awarded a £4,000 grant from Jersey Freemasons to cover the costs of maintaining and repairing its tools. The charity manages environmental projects, including the Val de la Mare Arboretum and the Alder Collection. The grant will ensure that JTFL can continue its vital tree care and maintenance work.
Læs mere »
Council's gully maintenance policy questionedCouncillor Patricia Ferguson raises concerns about the maintenance of roadside gullies in flood-prone areas. Council's response suggests a case-by-case approach to address the issue.
Læs mere »
Hospital Gene Therapy Aims to Free Patients from Chronic PainA new gene therapy treatment being developed at a hospital aims to provide long-term relief from chronic pain for patients. The therapy targets specific genes involved in pain signaling and aims to modify them to reduce pain sensitivity. Early trials have shown promising results, with patients experiencing significant pain reduction. If successful, this gene therapy could revolutionize the treatment of chronic pain and provide a much-needed alternative to opioids.
Læs mere »